Research Article: EPAS/HIF-? Acts as an Unanticipated Tumor-Suppressive Role in Papillary Thyroid Carcinoma
Abstract:
Papillary thyroid carcinoma (PTC) has significantly increased in the world over the past few decades, and it is the third most common solid malignancy. Most patients with PTC anticipated a relatively satisfactory clinical prognosis under the traditional therapy. However, part of PTC patients still posed the surgeons and oncologists a particularly difficult therapeutic challenge. Hence, a further exploration of the underlying molecular mechanisms involved in the unusually high aggressiveness events of PTC patients is clinically significant.
Introduction:
Papillary thyroid carcinoma (PTC) has significantly increased in the world over the past few decades, and it is the third most common solid malignancy. Most patients with PTC anticipated a relatively satisfactory clinical prognosis under the traditional therapy. However, part of PTC patients still posed the surgeons and oncologists a particularly difficult therapeutic challenge. Hence, a further exploration of the underlying molecular mechanisms involved in the unusually high aggressiveness events of PTC patients…
Read more